FDA warns against hydroxychloroquine use outside of hospital settings as prescriptions surge

(By Maia Anderson for Becker’s Hospita Review)

The FDA issued a warning April 24 against using hydroxychloroquine outside of a hospital setting or clinical trial due to the risk of serious heart problems as prescriptions have surged since the president began promoting the drug during his daily press briefings.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.